Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ovarian Neoplasms

Free Subscription 02.09.2024 1 Am J Obstet Gynecol 1 BMC Cancer 1 Cancer Lett 2 Eur J Obstet Gynecol Reprod Biol 3 Gynecol Oncol 4 Histopathology 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. DIOUN SM, Perez LR, Prabhu M, Brewer JT, et al
   Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention.
   Am J Obstet Gynecol. 2024 Apr 13:S0002-9378(24)00520.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. LIAO W, Li J, Feng W, Kong W, et al
   Pan-immune-inflammation value: a new prognostic index in epithelial ovarian cancer.
   BMC Cancer. 2024;24:1052.
   PubMed         Abstract available
   
   

   
   Cancer Lett

3. WU H, Sun C, Cao W, Teng Q, et al
   Blockade of the lncRNA-PART1-PHB2 axis confers resistance to PARP inhibitor and promotes cellular senescence in ovarian cancer.
   Cancer Lett. 2024;602:217192.
   PubMed         Abstract available
   
   

   
   Eur J Obstet Gynecol Reprod Biol

4. SCALIA P, Levin G, Lau S
   Pembrolizumab for metastatic squamous cell carcinoma arising from mature teratoma of the ovary: A letter to the editor.
   Eur J Obstet Gynecol Reprod Biol. 2024 Jul 31:S0301-2115(24)00421.
   PubMed        
   
   
5. MOSS E, Taylor A, Andreou A, Ang C, et al
   British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024.
   Eur J Obstet Gynecol Reprod Biol. 2024;300:69-123.
   PubMed        
   
   

   
   Gynecol Oncol

6. MEERNIK C, Osazuwa-Peters OL, Wilson LE, Joshi A, et al
   Frailty in patients with ovarian cancer and the role of healthcare access, race, and ethnicity.
   Gynecol Oncol. 2024;190:146-152.
   PubMed         Abstract available
   
   
7. QI C, Lyu M, Yao Z, Zhang F, et al
   SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-beta/Smad pathway.
   Gynecol Oncol. 2024;190:167-178.
   PubMed         Abstract available
   
   
8. SKOF E, Stegel V, Dragos VS, Blatnik A, et al
   Exploring the impact of BRCA1 and BRCA2 mutation type and location on Olaparib maintenance therapy in platinum-sensitive relapsed ovarian Cancer patients: A single center report.
   Gynecol Oncol. 2024;190:104-112.
   PubMed         Abstract available
   
   

   
   Histopathology

9. RICCI C, Ambrosi F, Grillini A, Grillini M, et al
   Immunophenotypical assessment supports that post-chemotherapy glandular tumours of germ cell origin straddle between glandular yolk sac tumour and 'somatic-type' adenocarcinoma.
   Histopathology. 2024;85:695-698.
   PubMed        
   
   
10. ALAFRAIDI M, Hoang L, Howitt BE, Longacre TA, et al
    The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profile.
    Histopathology. 2024;85:660-670.
    PubMed         Abstract available
    
    
11. MCHENRY A, Devereaux K, Ryan E, Chow S, et al
    Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low- and high-stage tumours.
    Histopathology. 2024;85:614-626.
    PubMed         Abstract available
    
    
12. WYVEKENS N, Mutter GL, Nucci MR, Kolin DL, et al
    Lesions sub-diagnostic of endometrioid intra-epithelial neoplasia/atypical hyperplasia: value of morphology and immunohistochemistry in predicting neoplastic outcome.
    Histopathology. 2024;85:579-589.
    PubMed         Abstract available
    
    

    
    PLoS One

13. ISINGIZWE ZR, Mortan LF, Benbrook DM
    Platelet and epithelial cell interations can be modeled in cell culture, and are not affected by dihomo-gamma-linolenic acid.
    PLoS One. 2024;19:e0309125.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.